HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Jon C Aster Selected Research
Jon C Aster Research Topics
Disease
62
Neoplasms (Cancer)
12/2022 - 01/2002
20
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
01/2020 - 01/2003
17
Leukemia
01/2020 - 02/2003
16
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2021 - 11/2004
9
Lymphoma (Lymphomas)
12/2022 - 06/2003
6
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
12/2022 - 02/2005
6
Hematologic Neoplasms (Hematological Malignancy)
11/2019 - 01/2010
5
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2020 - 11/2006
5
T-Cell Lymphoma (Lymphoma, T Cell)
10/2019 - 02/2009
5
Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2019 - 03/2010
4
B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
12/2021 - 11/2010
4
Disease Progression
01/2021 - 05/2007
4
Inflammation (Inflammations)
10/2020 - 06/2007
4
Melanoma (Melanoma, Malignant)
01/2018 - 02/2005
4
Carcinoma (Carcinomatosis)
03/2014 - 06/2008
4
Genetic Translocation (Chromosomal Translocation)
11/2004 - 09/2002
3
B-Cell Lymphoma (Lymphoma, B Cell)
01/2019 - 08/2005
3
Carcinogenesis
10/2014 - 02/2003
3
Infections
09/2011 - 04/2004
2
Sarcoma (Soft Tissue Sarcoma)
01/2020 - 01/2019
2
Atherosclerosis
01/2019 - 07/2012
2
Triple Negative Breast Neoplasms
01/2019 - 10/2014
2
Neutropenia
01/2018 - 04/2015
2
Adenoid Cystic Carcinoma (Cylindroma)
03/2016 - 10/2014
2
Squamous Cell Carcinoma (Epidermoid Carcinoma)
03/2014 - 10/2011
2
T-Cell Leukemia (Leukemia, T Cell)
11/2012 - 07/2007
2
Myeloproliferative Disorders (Myeloproliferative Disorder)
10/2008 - 12/2003
2
Hodgkin Disease (Hodgkin's Disease)
08/2005 - 02/2005
2
Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
02/2005 - 09/2002
1
Glomus Tumor (Glomus Tumors)
01/2022
1
Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
12/2021
1
Communicable Diseases (Infectious Diseases)
01/2021
1
Edema (Dropsy)
10/2020
1
Myofibroma
04/2020
1
Glucocorticoid Receptor Deficiency
01/2020
1
Adenocarcinoma
01/2020
1
alpha-Thalassemia
01/2019
Drug/Important Bio-Agent (IBA)
13
Proteins (Proteins, Gene)
FDA Link
12/2022 - 06/2003
13
Amyloid Precursor Protein Secretases (beta-Secretase)
IBA
01/2022 - 07/2004
10
Ligands
IBA
12/2021 - 10/2004
8
Notch Receptors
IBA
01/2020 - 01/2003
6
Antigens
IBA
01/2021 - 06/2006
6
RNA (Ribonucleic Acid)
IBA
01/2021 - 04/2004
6
Transcription Factors (Transcription Factor)
IBA
11/2019 - 02/2007
5
Phosphotransferases (Kinase)
IBA
01/2021 - 02/2014
5
Biomarkers (Surrogate Marker)
IBA
10/2018 - 10/2014
4
Cytokines
IBA
01/2021 - 09/2014
4
Pharmaceutical Preparations
IBA
11/2016 - 02/2003
3
Cyclophosphamide (Cytoxan)
FDA Link
Generic
12/2022 - 01/2002
3
Antibodies
IBA
10/2019 - 02/2010
3
Chromatin
IBA
01/2019 - 01/2014
3
Biological Products
IBA
01/2019 - 11/2012
3
Oncogene Proteins (Oncogene Protein)
IBA
02/2014 - 02/2004
3
Notch1 Receptor
IBA
02/2008 - 11/2004
2
Vincristine (Oncovin)
FDA Link
Generic
12/2022 - 01/2002
2
Doxorubicin (Adriamycin)
FDA Link
Generic
12/2022 - 01/2002
2
Prednisone (Sone)
FDA Link
Generic
12/2022 - 01/2002
2
Serine (L-Serine)
FDA Link
12/2021 - 01/2010
2
Threonine (L-Threonine)
FDA Link
12/2021 - 01/2010
2
Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)
IBA
04/2020 - 12/2003
2
Genie
IBA
01/2020 - 01/2019
2
DNA (Deoxyribonucleic Acid)
IBA
11/2019 - 04/2004
2
Small Interfering RNA (siRNA)
IBA
01/2019 - 10/2012
2
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
10/2018 - 02/2007
2
Sirolimus (Rapamycin)
FDA Link
01/2018 - 07/2007
2
Vaccines
IBA
01/2018 - 01/2017
2
Protein Kinases (Protein Kinase)
IBA
05/2017 - 01/2010
2
Syk Kinase
IBA
01/2016 - 02/2014
2
Monoclonal Antibodies
IBA
06/2015 - 07/2009
2
Complementary DNA (cDNA)
IBA
03/2013 - 02/2008
2
Polychlorinated Biphenyls (PCBs)
IBA
05/2010 - 03/2010
2
Dichlorodiphenyl Dichloroethylene (DDE)
IBA
05/2010 - 03/2010
2
Nuclear Proteins (Protein, Nuclear)
IBA
07/2009 - 06/2008
2
Cyclin D3
IBA
02/2009 - 12/2003
2
Green Fluorescent Proteins
IBA
04/2006 - 02/2003
2
Presenilins
IBA
07/2004 - 01/2003
1
Rituximab (Mabthera)
FDA Link
12/2022
1
carboxyl radical (COO-)
IBA
12/2022
1
Proline (L-Proline)
FDA Link
12/2021
1
Glutamic Acid (Glutamate)
FDA Link
12/2021
1
chenodeoxycholate sulfate conjugate (CDCS)
IBA
01/2021
1
Bacterial Toxins
IBA
01/2021
1
tyrosine receptor (receptor, tyrosine)
IBA
01/2021
1
Small Cytoplasmic RNA
IBA
01/2021
1
Lipids
IBA
10/2020
1
2- (1H- indazol- 4- yl)- 6- (4- methanesulfonylpiperazin- 1- ylmethyl)- 4- morpholin- 4- ylthieno(3,2- d)pyrimidine
IBA
01/2020
1
Glucocorticoids
IBA
01/2020
1
Core Binding Factors (Core-Binding Factor)
IBA
01/2020
1
Dexamethasone (Maxidex)
FDA Link
Generic
01/2020
1
Glucocorticoid Receptors (Glucocorticoid Receptor)
IBA
01/2020
1
Azacitidine (5 Azacytidine)
FDA Link
11/2019
1
Interleukin-3 Receptors (Interleukin 3 Receptor)
IBA
11/2019
1
tagraxofusp
IBA
11/2019
1
Alemtuzumab (Campath)
FDA Link
01/2019
1
Toll-Like Receptors (Toll-Like Receptor)
IBA
01/2019
1
Interferons
IBA
01/2019
Therapy/Procedure
23
Therapeutics
01/2021 - 07/2004
4
Drug Therapy (Chemotherapy)
11/2018 - 01/2002
2
Immunotherapy
01/2021 - 01/2016
1
Nephrectomy
01/2019